Cambridge, MA – The Bulfinch Companies, Inc. (Bulfinch), a private, real estate investment, development and management firm, announces an affiliate of the company has acquired 1120 Massachusetts Avenue, a 7,200sf building located in the heart of Harvard Square.
The acquisition represents Bulfinch’s 13th property in the booming technology, life science and biotech hub of Cambridge. Bulfinch plans to redevelop and reposition the asset as a first-class office, medical or biotech property, complete with a roof deck.
The building has two stories above grade and one below, with floor-to-ceiling windows on the street providing high visibility and ample daylighting. Ideally situated a short walk from Boston’s “Brain Train” at the Harvard Square Red Line T stop, the property is just steps away from a variety of shops, restaurants and vibrant business centers at Harvard Square and Central Square.
The acquisition of 1120 Massachusetts Avenue represents a continued commitment to Bulfinch’s mission, Discover + Deliver, as the company works with passion, creativity and collaboration with tenants and investors to create exceptional workplaces.
